Cargando…
Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy
Craniopharyngiomas are histologically benign but locally aggressive tumors in the sellar region that may cause devastating neurological and endocrine deficits. They tend to recur following surgery with high morbidity; hence, postoperative radiotherapy is recommended following sub-total resection. BR...
Autores principales: | Rostami, Elham, Witt Nyström, Petra, Libard, Sylwia, Wikström, Johan, Casar-Borota, Olivera, Gudjonsson, Olafur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636852/ https://www.ncbi.nlm.nih.gov/pubmed/28918496 http://dx.doi.org/10.1007/s00701-017-3311-0 |
Ejemplares similares
-
Retrospective dataset and survey analyses identify gaps in data collection for craniopharyngioma and priorities of patients and families affected by the disease
por: Marshall, Emily, et al.
Publicado: (2023) -
THU084 Corticotroph Tumor Type Influences Clinical Presentation In Patients With Nonfunctioning Pituitary Neuroendocrine Tumors
por: Al-Shamkhi, Nasrin, et al.
Publicado: (2023) -
Hypofractionated high-energy proton-beam irradiation is an alternative treatment for WHO grade I meningiomas
por: Vlachogiannis, Pavlos, et al.
Publicado: (2017) -
The clinical significance of BRAFV600E mutations in pediatric papillary thyroid carcinomas
por: Li, Yangsen, et al.
Publicado: (2022) -
Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis
por: Tebani, Abdellah, et al.
Publicado: (2021)